Mauro Di Ianni

Pescara, 65124, Italy

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 75 publications

Focus on Women with Hemophilia and Carriers: How to Address All the Existing Gaps in Diagnosis and Care.

Focus on Women with Hemophilia and Carriers: How to Address All the Existing Gaps in Diagnosis and Care.

Journal: Journal of clinical medicine
Published: June 22, 2026

CAR-T TEMRA and CAR-Tregs in vivo expansion are both associated with a poor response after CD19.CAR-T therapy.

CAR-T TEMRA and CAR-Tregs in vivo expansion are both associated with a poor response after CD19.CAR-T therapy.

Journal: Bone marrow transplantation
Published: April 10, 2026

Case Report: Refractory cold agglutinin disease with hypersplenism: efficacy of splenectomy in a patient treated with sutimlimab.

Case Report: Refractory cold agglutinin disease with hypersplenism: efficacy of splenectomy in a patient treated with sutimlimab.

Journal: Frontiers in immunology
Published: December 23, 2025

A Combination of Plerixafor and Filgrasting Promotes Successful CD34+ Cell Collection for CRISPR/Cas9 Therapy in Sickle Cell Disease Patients With Insufficient Response to Plerixafor Alone.

A Combination of Plerixafor and Filgrasting Promotes Successful CD34+ Cell Collection for CRISPR/Cas9 Therapy in Sickle Cell Disease Patients With Insufficient Response to Plerixafor Alone.

Journal: American journal of hematology
Published: August 27, 2025

Rab GTPases drive ligand-independent NOTCH1 activation via altered endocytic trafficking in chronic lymphocytic leukemia.

Rab GTPases drive ligand-independent NOTCH1 activation via altered endocytic trafficking in chronic lymphocytic leukemia.

Journal: HemaSphere
Published: August 18, 2025

CXCR4-dependent migratory differences between peripheral Tregs and Tcons preserve GvL while limiting GvHD after HSCT.

CXCR4-dependent migratory differences between peripheral Tregs and Tcons preserve GvL while limiting GvHD after HSCT.

Journal: Blood advances
Published: August 06, 2025

Nonstandard superficial vein thrombosis management. Should we consider a tailored approach? A critical review and discussion.

Nonstandard superficial vein thrombosis management. Should we consider a tailored approach? A critical review and discussion.

Journal: Polish archives of internal medicine
Published: May 12, 2025

Genetic insights into myeloproliferative neoplasms and unusual sites thrombosis.

Genetic insights into myeloproliferative neoplasms and unusual sites thrombosis.

Journal: Annals of hematology
Published: May 07, 2025

Cytomegalovirus infection after autologous transplantation in patients with multiple myeloma exposed to daratumumab.

Cytomegalovirus infection after autologous transplantation in patients with multiple myeloma exposed to daratumumab.

Journal: Bone marrow transplantation
Published: February 17, 2025

Case Report: A case of pediatric persistent refractory ITP responsive to avatrombopag.

Case Report: A case of pediatric persistent refractory ITP responsive to avatrombopag.

Journal: Frontiers in immunology
Published: February 13, 2025

Low Phosphatidylserine+ Cells Within the CD34+/CD45dim/CD117(c-kit)+ Subpopulation Are Associated with Poor Outcomes in Metastatic Colorectal Cancer.

Low Phosphatidylserine+ Cells Within the CD34+/CD45dim/CD117(c-kit)+ Subpopulation Are Associated with Poor Outcomes in Metastatic Colorectal Cancer.

Journal: Cancers
Published: December 28, 2024

Dosing and clinical outcomes of ruxolitinib in patients with myelofibrosis in a real-world setting: Interim results of the Italian observational study (ROMEI).

Dosing and clinical outcomes of ruxolitinib in patients with myelofibrosis in a real-world setting: Interim results of the Italian observational study (ROMEI).

Journal: Cancer
Published: October 24, 2024
Showing 1-12 of 75

Last Updated: 09/26/2026